Sanofi is poised to terminate its Auvi-Q marketing deal says PDL Biopharma, citing manufacturing issues last year which led to a complete recall of the epinephrine injection product.
India is considering strengthening compulsory licensing provisions, which allow third parties to produce patented products, in response to concerns about overseas takeovers and drug prices.
Winsunny Pharma has exclusively licensed NMT’s HGCP technology, which produces APIs in low micron and nano-sized range, to manufacture a hyperlipidemia-controlling drug in China.
UK drug delivery company SkyePharma has reported net losses down in
the first half of the year, but warned revenues and cash flow will
come under pressure as it moves away from its current
milestone-based revenue model.
UK drug delivery company SkyePharma expects to make a loss in 2003,
a disappointing result given that it chalked up its first
profitable year just a year earlier, and will cut 10 per cent of
its workforce as a result.
Ireland's Elan Corp has signed up another heavyweight partner -
Janssen - for its NanoCrystals technology, designed to improve the
solubility of drug compounds.
Cambridge Antibody Technology of the UK has signed up for a
non-exclusive licence to a technology, developed by Canada's
Chromos Molecular Systems, for the commercial manufacture of
biologics.